Isofol Medical AB (FRA:5IU) E10: €-0.11 (As of Mar. 2026)


FRA:5IU Isofol Medical AB FRA:5IU
30 GF Score
Price €0.06
! 2 Warning Signs
View Full Analysis

What is Isofol Medical AB E10?

Isofol Medical AB FRA:5IU -10.53% 30 E10 is €-0.11 as of Mar. 2026. GuruFocus rates FRA:5IU with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Isofol Medical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.005. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.11 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-13), Isofol Medical AB's current stock price is €0.0552. Isofol Medical AB's E10 for the quarter that ended in Mar. 2026 was €-0.11. Isofol Medical AB's Shiller PE Ratio of today is .


Isofol Medical AB  (FRA:5IU) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Isofol Medical AB E10 Related Terms


Isofol Medical AB E10 Historical Data

* Premium members only.

The historical data trend for Isofol Medical AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isofol Medical AB E10 Chart

Isofol Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.11

Isofol Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.11 -0.11

FRA:5IU vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Isofol Medical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Isofol Medical AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Isofol Medical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Isofol Medical AB's Shiller PE Ratio falls into.


FRA:5IU
30GF Score
Isofol Medical AB FRA:5IU
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Isofol Medical AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Isofol Medical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.005/133.5600*133.5600
=-0.005

Current CPI (Mar. 2026) = 133.5600.

Isofol Medical AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.034 101.019 -0.045
201609 -0.028 101.138 -0.037
201612 -0.098 102.022 -0.128
201703 -0.041 102.022 -0.054
201706 -0.022 102.752 -0.029
201709 -0.038 103.279 -0.049
201712 -0.047 103.793 -0.060
201803 -0.031 103.962 -0.040
201806 -0.026 104.875 -0.033
201809 -0.026 105.679 -0.033
201812 -0.044 105.912 -0.055
201903 -0.040 105.886 -0.050
201906 -0.071 106.742 -0.089
201909 -0.085 107.214 -0.106
201912 -0.086 107.766 -0.107
202003 -0.111 106.563 -0.139
202006 -0.087 107.498 -0.108
202009 -0.024 107.635 -0.030
202012 -0.045 108.296 -0.055
202103 -0.035 108.360 -0.043
202106 -0.042 108.928 -0.051
202109 -0.028 110.338 -0.034
202112 -0.032 112.486 -0.038
202203 -0.025 114.825 -0.029
202206 -0.027 118.384 -0.030
202209 -0.016 122.296 -0.017
202212 -0.013 126.365 -0.014
202303 -0.007 127.042 -0.007
202306 -0.004 129.407 -0.004
202309 -0.003 130.224 -0.003
202312 -0.004 131.912 -0.004
202403 -0.004 132.205 -0.004
202406 -0.006 132.716 -0.006
202409 -0.006 132.304 -0.006
202412 -0.007 132.987 -0.007
202503 -0.007 132.825 -0.007
202506 -0.008 133.699 -0.008
202509 -0.005 133.480 -0.005
202512 -0.005 133.390 -0.005
202603 -0.005 133.560 -0.005

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.11 mean?
Isofol Medical AB (FRA:5IU) has a E10 of €-0.11 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Isofol Medical AB and its competitors.
Is Isofol Medical AB's E10 too high?
Isofol Medical AB's current E10 is €-0.11. Overall, Isofol Medical AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Isofol Medical AB's E10 compare to VRTX and REGN?
Isofol Medical AB's E10 of €-0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Isofol Medical AB and its competitors. Isofol Medical AB's current E10 is €-0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Isofol Medical AB stock overvalued right now?
Isofol Medical AB (FRA:5IU) has a current E10 of €-0.11. The current E10 is €-0.11. Isofol Medical AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Isofol Medical AB (FRA:5IU), the current E10 is €-0.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Isofol Medical AB Business Description

Other Exchanges ISOFOL:Sweden
Address Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.
30GF Score

Get the complete analysis for FRA:5IU

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price